ATA115186A - Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung - Google Patents

Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung

Info

Publication number
ATA115186A
ATA115186A AT1151/86A AT115186A ATA115186A AT A115186 A ATA115186 A AT A115186A AT 1151/86 A AT1151/86 A AT 1151/86A AT 115186 A AT115186 A AT 115186A AT A115186 A ATA115186 A AT A115186A
Authority
AT
Austria
Prior art keywords
producing
pharmaceutical preparation
protecting effect
protecting
effect
Prior art date
Application number
AT1151/86A
Other languages
English (en)
Other versions
AT393793B (de
Inventor
Pierre-Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of ATA115186A publication Critical patent/ATA115186A/de
Application granted granted Critical
Publication of AT393793B publication Critical patent/AT393793B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT0115186A 1985-04-30 1986-04-29 Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung AT393793B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1826/85A CH662505A5 (it) 1985-04-30 1985-04-30 Composizioni farmaceutiche ad azione protettiva vascolare.

Publications (2)

Publication Number Publication Date
ATA115186A true ATA115186A (de) 1991-06-15
AT393793B AT393793B (de) 1991-12-10

Family

ID=4219499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0115186A AT393793B (de) 1985-04-30 1986-04-29 Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung

Country Status (10)

Country Link
US (1) US4707360A (de)
JP (1) JPS61280424A (de)
KR (1) KR860007927A (de)
AT (1) AT393793B (de)
BE (1) BE904696A (de)
CH (1) CH662505A5 (de)
DE (1) DE3614278A1 (de)
FR (1) FR2587212B1 (de)
GB (2) GB8610147D0 (de)
NL (1) NL8601105A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383171A3 (de) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-Trihydroxy-urs-12-en Derivate zur Behandlung von Kognitiven Störungen
FR2645442A1 (fr) * 1989-04-07 1990-10-12 Gueyne Jean Produit therapeutique a base de compose organique du silicium et de polyamine polycarboxylee, particulierement utile pour le traitement de l'atherome
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
IE911403A1 (en) * 1990-04-26 1991-11-06 Cytrx Corp Compositions and method for topical treatment of damaged or¹diseased tissue
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
FR2692145B1 (fr) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger Nouvelle composition à usage topique contenant de la diosmine.
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
GB9425487D0 (en) 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
US5683678A (en) * 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
WO1998023278A1 (en) * 1996-11-27 1998-06-04 Dong Kook Pharmaceutical Co., Ltd. Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives
KR100530278B1 (ko) * 1997-02-28 2006-04-06 동국제약 주식회사 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders
US6159494A (en) * 1997-12-03 2000-12-12 Widgerow; Alan D Treatment of post operative scars with a tape containing a gel from Bulbine frutescens
US6423742B1 (en) 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
US6562864B1 (en) 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
DE60017762T8 (de) * 1999-09-10 2006-08-24 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano Ein antioxydierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislauf--und chronischen degenerativen problemen und von bluthochdruck
EP1214084B1 (de) * 1999-09-10 2005-04-06 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale di Lugano Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen
WO2002069992A1 (en) * 2001-03-02 2002-09-12 Biopharmacopae Design International Inc. Plant extracts and compositions comprising extracellular protease inhibitors
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
DE20109044U1 (de) * 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US6981883B2 (en) * 2001-11-14 2006-01-03 Fci Americas Technology, Inc. Impedance control in electrical connectors
EP1591020A4 (de) * 2003-01-17 2006-04-26 Taiyo Kagaku Kk Coenzym q10-haltige zusammensetzungen
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
EP2353596A1 (de) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Kombinationszusammensetzung mit L-Carnitin oder Proponyl-L-Carnitin als Wirkstoffe zur Vorbeugung oder Behandlung von chronischer Veneninsuffizienz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
CH670763A5 (de) * 1985-08-02 1989-07-14 Seuref Ag

Also Published As

Publication number Publication date
FR2587212B1 (fr) 1992-05-29
JPH0344048B2 (de) 1991-07-04
GB2174904B (en) 1989-07-05
FR2587212A1 (fr) 1987-03-20
DE3614278A1 (de) 1986-10-30
JPS61280424A (ja) 1986-12-11
GB8610147D0 (en) 1986-05-29
GB8610588D0 (en) 1986-06-04
KR860007927A (ko) 1986-11-10
US4707360A (en) 1987-11-17
AT393793B (de) 1991-12-10
BE904696A (nl) 1986-08-18
GB2174904A (en) 1986-11-19
NL8601105A (nl) 1986-11-17
CH662505A5 (it) 1987-10-15

Similar Documents

Publication Publication Date Title
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
ATA177587A (de) Verfahren zur herstellung eines stabilen pharmazeutischen präparats mit einem gehalt an granulozytkolonie stimulierendem faktor
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
DE3679975D1 (de) Verfahren zur herstellung eines werkstoffes mit einem abhaengigen gradienten.
PT86828A (pt) Verfahren zur herstellung eines pharmazeutischen pflasters
DE3667489D1 (de) Verfahren zur herstellung eines proteins.
DE3687502D1 (de) Verfahren zur herstellung eines wasserundurchlaessigen stoffes.
ATA170086A (de) Verfahren zur herstellung einer festen haltbaren darreichungsform
AT385199B (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit verzoegerter wirkstofffreigabe
AT383758B (de) Verfahren zur herstellung eines sputter-targets
ATA318081A (de) Verfahren zur herstellung von topischen verfahren zur herstellung von topischen pharmazeutischen zubereitungen pharmazeutischen zubereitungen
DE68918016D1 (de) Verfahren zur Herstellung eines Dimethyltetralins.
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
DE3769662D1 (de) Verfahren zur herstellung eines stabilen nicorandilpraeparats.
DE3671355D1 (de) Verfahren zur herstellung eines gewuerzes.
AT385653B (de) Verfahren zur herstellung eines zahnputzmittels
DE3687954D1 (de) Verfahren zur herstellung eines tetraalkoxysilans.
DE3680887D1 (de) Verfahren zur herstellung eines farbbildes.
ATA18588A (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE68902580D1 (de) Verfahren zur herstellung eines oligosaccharid enthaltenden brots.
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
DE3687721D1 (de) Verfahren zur herstellung eines plasminogenaktivators fuer gewebe.
ATA207887A (de) Verfahren zur herstellung eines pharmazeutischen nicorandilpraeparats zur perkutanen absorption

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee